EPHA2 and neoplasm: Virus-based tumor antigen expression not only induces tumor-infiltrating leukocyte (TIL) and peripheral immune cell phenotypical changes but also produces functional populations with an improved Epha2 antigen response capable of suppressing tumor growth on rechallenge of survivors.